Shire plc (SHPG) Raising PT - Leerink

Leerink Partners analyst, Jason Gerberry, reiterated his Outperform rating on shares of Shire (NASDAQ: SHPG) after the company reported solid 2Q results, beating the topline forecast by 6% and EPS by 10%, while the pending Xiidra (dry eye) launch and higher than expected cost synergies from the Baxalta deal underpin the analyst's 17% 2-year EPS growth CAGR (2017-19).

The price target of $231 is increased from $213.

For an analyst ratings summary and ratings history on Shire click here. For more ratings news on Shire click here.

Shares of Shire closed at $202.24 yesterday.

You May Also Be Interested In

• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
• BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
• Equifax (EFX) PT Lowered to $263 at Citi